Literature DB >> 10486322

Temperature-sensitive RB mutations linked to incomplete penetrance of familial retinoblastoma in 12 families.

G A Otterson1, S Modi, K Nguyen, A B Coxon, F J Kaye.   

Abstract

The tumor-suppressor activity of the retinoblastoma protein (RB) is encoded within a protein-binding ("pocket") domain that is targeted for mutations in all cases of familial retinoblastoma and in many common adult cancers. Although familial retinoblastoma is a paradigm for a highly penetrant, recessive model of tumorigenesis, the molecular basis for the phenotype of incomplete penetrance of familial retinoblastoma is undefined. We studied the RB pocket-binding properties of three independent, mutant RB alleles that are present in the germline of 12 kindreds with the phenotype of incomplete penetrance of familial retinoblastoma. Each arises from alterations of single codons within the RB pocket domain (designated "delta 480," "661W," or "712R"). Under the same conditions, we studied the properties of wild-type (WT) RB, an RB point mutant isolated from a lung carcinoma sample (706F) and an adjacent, in vitro-generated point mutant (707W). The delta 480, 661W, and 712R mutants lack pocket protein-binding activity in vitro but retain the WT ability to undergo cyclin-mediated phosphorylation in vivo. Each of the low-penetrant RB mutants exhibits marked enhancement of pocket protein binding when the cells are grown at reduced temperature. In contrast, in this temperature range, no change in binding activity is seen with WT RB, the 706F mutant, or the 707W mutant. We have demonstrated that many families with incomplete penetrance of familial retinoblastoma carry unstable, mutant RB alleles with temperature-sensitive pocket protein-binding activity. The variable frequency for tumor development in these families may result from reversible fluctuations in a threshold level of RB pocket-binding activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486322      PMCID: PMC1288236          DOI: 10.1086/302581

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

1.  Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product.

Authors:  W G Kaelin; D C Pallas; J A DeCaprio; F J Kaye; D M Livingston
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

2.  RB1 gene mutations in peripheral blood DNA of patients with isolated unilateral retinoblastoma.

Authors:  M Klutz; B Horsthemke; D R Lohmann
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

3.  [Retinoma and phtisis bulbi: benign expression of retinoblastoma].

Authors:  A Balmer; F Munier; C Gailloud
Journal:  Klin Monbl Augenheilkd       Date:  1992-05       Impact factor: 0.700

4.  A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding.

Authors:  F J Kaye; R A Kratzke; J L Gerster; J M Horowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma.

Authors:  V Greger; E Passarge; W Höpping; E Messmer; B Horsthemke
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

6.  Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene.

Authors:  T Sakai; N Ohtani; T L McGee; P D Robbins; T P Dryja
Journal:  Nature       Date:  1991-09-05       Impact factor: 49.962

7.  Retinoma. Case studies.

Authors:  A Balmer; F Munier; C Gailloud
Journal:  Ophthalmic Paediatr Genet       Date:  1991-09

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

Authors:  J W Harbour; S L Lai; J Whang-Peng; A F Gazdar; J D Minna; F J Kaye
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

10.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

View more
  15 in total

1.  The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes.

Authors:  Hai Xiao; David W Goodrich
Journal:  Oncogene       Date:  2005-12-08       Impact factor: 9.867

Review 2.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

3.  An E2F binding-deficient Rb1 protein partially rescues developmental defects associated with Rb1 nullizygosity.

Authors:  Huifang Sun; Yanjie Chang; Brett Schweers; Michael A Dyer; Xiaojing Zhang; Simon W Hayward; David W Goodrich
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

4.  Detection of allelic imbalance in the gene expression of hMSH2 or RB1 in lymphocytes from pedigrees of hereditary, nonpolyposis, colorectal cancer and retinoblastoma by an RNA difference plot.

Authors:  Yoshinori Murakami; Kana Isogai; Hiroyuki Tomita; Mika Sakurai-Yageta; Tomoko Maruyama; Akio Hidaka; Kiyoshi Nose; Kokichi Sugano; Akihiro Kaneko
Journal:  J Hum Genet       Date:  2004-10-08       Impact factor: 3.172

5.  Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras.

Authors:  Yoonsoo Park; Akihito Kubo; Takefumi Komiya; Amy Coxon; Kristin Beebe; Len Neckers; Paul S Meltzer; Frederic J Kaye
Journal:  Cell Cycle       Date:  2008-05-30       Impact factor: 4.534

6.  A Novel von Hippel Lindau Gene Intronic Variant and Its Reclassification from VUS to Pathogenic: the Impact on a Large Family.

Authors:  A Sexton; L Rawlings; G McKavanagh; K Simons; I Winship
Journal:  J Genet Couns       Date:  2015-09-02       Impact factor: 2.537

7.  Molecular-genetic analysis of two cases with retinoblastoma: benefits for disease management.

Authors:  Govindasamy Kumaramanickavel; Biju Joseph; Komaravelly Narayana; Sribhargava Natesh; Gandra Mamatha; Mahesh P Shanmugam; Anuradha Elamparathi; Jyotirmay Biswas
Journal:  J Genet       Date:  2003 Apr-Aug       Impact factor: 1.166

8.  Folding of a cyclin box: linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor AB pocket domain.

Authors:  Lucía B Chemes; María G Noval; Ignacio E Sánchez; Gonzalo de Prat-Gay
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

9.  RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database.

Authors:  José R Valverde; Javier Alonso; Itziar Palacios; Angel Pestaña
Journal:  BMC Genet       Date:  2005-11-04       Impact factor: 2.797

10.  Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts?

Authors:  Frederick A Dick
Journal:  Cell Div       Date:  2007-09-13       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.